Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1111 | 1112 | (Page 1113) | 1114 | 1115 | .... | 1146 | newer

    0 0

     



    (EMAILWIRE.COM, December 11, 2018 ) Publisher "Chemotherapy Induced Neutropenia - Epidemiology Forecast To 2023" provides an overview of the epidemiology trends of Chemotherapy Induced Neutropenia in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Chemotherapy Induced Neutropenia prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Chemotherapy Induced Neutropenia . The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

    Get a Sample Report:   https://www.reportsweb.com/inquiry&RW0001889406/sample

    Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

    Scope of the Report
    - The Report includes the prevalent population and how will it change over the next eight years.
    - Prevalent or incident cases segmented by age and sex.
    - Coverage of key Chemotherapy Induced Neutropenia subpopulations and its prevalent or incident cases
    - The key differences in epidemiology patterns across the seven market segments

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW0001889406/discount

    Key Coverage and Benefits
    - The report will help in developing business strategies by understanding the trends shaping and driving the global Chemotherapy Induced Neutropenia market.
    - Identifying prevalent patient populations as well as risk factors in the global Chemotherapy Induced Neutropenia market will help to improve product design, pricing, and launch plans.
    - Organize sales and marketing efforts by identifying the best opportunities for Chemotherapy Induced Neutropenia therapeutics in each of the markets covered.

    Get More Information : https://www.reportsweb.com/inquiry&RW0001889406/buying


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 11, 2018 ) Publisher's "Actinic Keratosis - Epidemiology Insights, 2023" report provides an overview of the disease of the Actinic Keratosis for the United States, EU5 France, Germany, Italy, Spain, UK and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Actinic Keratosis from 2013-2023.

    Get a Sample Report:   https://www.reportsweb.com/inquiry&RW0001889407/sample

    Actinic Keratosis AK commonly known as a solar keratosis is a precancerous crusty lesion caused by damage from exposure to ultraviolet UV radiation. It is considered a pre-cancer condition if left untreated could develop into a skin cancer, most often squamous cell carcinoma SCC. AKs appear on areas which are most commonly exposed to sun such as the face, scalp, shoulders, neck, the back of the hands and forearms, etc.

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW0001889407/discount

    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

    Scope
    The report provides historical as well as forecasted epidemiology of Actinic Keratosis in the 7MM.
    Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

    Get More Information : https://www.reportsweb.com/inquiry&RW0001889407/buying


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 11, 2018 ) Publisher " Asthma - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Asthma in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Asthma prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Asthma. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

    Get a Sample Report:   https://www.reportsweb.com/inquiry&RW0001889408/sample

    Scope of the Report
    The Report includes the prevalent population and how will it change over the next eight years.
    Prevalent or incident cases segmented by age and sex.
    Coverage of key Asthma subpopulations and its prevalent or incident cases
    The key differences in epidemiology patterns across the seven market segments

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW0001889408/discount

    Key Coverage and Benefits
    The report will help in developing business strategies by understanding the trends shaping and driving the global Asthma market.
    Identifying prevalent patient populations as well as risk factors in the global Asthma market will help to improve product design, pricing, and launch plans.
    Organize sales and marketing efforts by identifying the best opportunities for Asthma therapeutics in each of the markets covered.

    Get More Information : https://www.reportsweb.com/inquiry&RW0001889408/buying


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 11, 2018 ) Publisher " Acne Vulgaris - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acne Vulgaris in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acne Vulgaris prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Acne Vulgaris. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

    Get a Sample Report: https://www.reportsweb.com/inquiry&RW0001889409/sample

    Scope of the Report
    The Report includes the prevalent population and how will it change over the next eight years.
    Prevalent or incident cases segmented by age and sex.
    Coverage of key Acne Vulgaris subpopulations and its prevalent or incident cases
    The key differences in epidemiology patterns across the seven market segments

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW0001889409/discount

    Key Coverage and Benefits
    The report will help in developing business strategies by understanding the trends shaping and driving the global Acne Vulgaris market.
    Identifying prevalent patient populations as well as risk factors in the global Acne Vulgaris market will help to improve product design, pricing, and launch plans.
    Organize sales and marketing efforts by identifying the best opportunities for Acne Vulgaris therapeutics in each of the markets covered.

    Get More Information : https://www.reportsweb.com/inquiry&RW0001889409/buying


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 11, 2018 ) The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pain Management Devices pipeline products.



    This report is prepared using data sourced from in-house databases, secondary and primary research by Publisher's team of industry experts.

    Get Access to Report Sample: @ https://www.reportsweb.com/inquiry&RW00012150920/sample
    Scope

    -Extensive coverage of the Pain Management Devices under development

    -The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

    -The report reviews the major players involved in the development of Pain Management Devices and list all their pipeline projects

    -The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

    -The report provides key clinical trial data of ongoing trials specific to pipeline products

    -Recent developments in the segment / industry.

    Get Up-to 50% Discount for this report @ https://www.reportsweb.com/inquiry&RW00012150920/discount



    Table of Content

    1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
    1.5 Market by Application
    1.6 Study Objectives
    1.7 Years Considered

    2 Global Growth Trends
    2.1 Pain Management Devices Market Size
    2.2 Pain Management Devices Growth Trends by Regions
    2.3 Industry Trends

    3 Market Share by Key Players
    3.1 Pain Management Devices Market Size by Manufacturers
    3.2 Pain Management Devices Key Players Head office and Area Served
    3.3 Key Players Pain Management Devices Product/Solution/Service
    3.4 Date of Enter into Pain Management Devices Market
    3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product
    4.1 Global Pain Management Devices Sales by Product
    4.2 Global Pain Management Devices Revenue by Product
    4.3 Pain Management Devices Price by Product

    5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Pain Management Devices Breakdown Data by End User

    Get More Information @ https://www.reportsweb.com/inquiry&RW00012150920/discount


    Reasons to Purchase this Report:

    The report enables you to-

    -Formulate significant competitor information, analysis, and insights to improve R&D strategies

    -Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

    -Identify and understand important and diverse types of Pain Management Devices under development

    -Develop market-entry and market expansion strategies

    -Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

    -In-depth analysis of the product's current stage of development, territory and estimated launch date.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 11, 2018 ) The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wireless and Ambulatory Monitoring pipeline products.

    This report is prepared using data sourced from in-house databases, secondary and primary research by Publisher's team of industry experts.

    Get Access to Report Sample: @ https://www.reportsweb.com/inquiry&RW00012150924/sample

    Scope

    -Extensive coverage of the Wireless and Ambulatory Monitoring under development

    -The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

    -The report reviews the major players involved in the development of Wireless and Ambulatory Monitoring and list all their pipeline projects

    -The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

    -The report provides key clinical trial data of ongoing trials specific to pipeline products

    -Recent developments in the segment / industry.

    Get Up-to 50% Discount for this report @ https://www.reportsweb.com/inquiry&RW00012150924/discount

    Table of Content

    1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
    1.5 Market by Application
    1.6 Study Objectives
    1.7 Years Considered

    2 Global Growth Trends
    2.1 Wireless and Ambulatory Monitoring Market Size
    2.2 Wireless and Ambulatory Monitoring Growth Trends by Regions
    2.3 Industry Trends

    3 Market Share by Key Players
    3.1 Wireless and Ambulatory Monitoring Market Size by Manufacturers
    3.2 Wireless and Ambulatory Monitoring Key Players Head office and Area Served
    3.3 Key Players Wireless and Ambulatory Monitoring Product/Solution/Service
    3.4 Date of Enter into Wireless and Ambulatory Monitoring Market
    3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product
    4.1 Global Wireless and Ambulatory Monitoring Sales by Product
    4.2 Global Wireless and Ambulatory Monitoring Revenue by Product
    4.3 Wireless and Ambulatory Monitoring Price by Product

    5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Wireless and Ambulatory Monitoring Breakdown Data by End User

    Get More Information @ https://www.reportsweb.com/inquiry&RW00012150924/buying

    Reasons to Purchase this Report:
    The report enables you to-

    -Formulate significant competitor information, analysis, and insights to improve R&D strategies

    -Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

    -Identify and understand important and diverse types of Wireless and Ambulatory Monitoring under development

    -Develop market-entry and market expansion strategies

    -Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

    -In-depth analysis of the product's current stage of development, territory and estimated launch date.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 11, 2018 ) The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Patient Monitoring Accessories pipeline products.

    This report is prepared using data sourced from in-house databases, secondary and primary research by Publisher's team of industry experts.


    Get Access to Report Sample: @ https://www.reportsweb.com/inquiry&RW00012150924/sample

    Scope

    -Extensive coverage of the Patient Monitoring Accessories under development

    -The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

    -The report reviews the major players involved in the development of Patient Monitoring Accessories and list all their pipeline projects

    -The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

    -The report provides key clinical trial data of ongoing trials specific to pipeline products

    -Recent developments in the segment / industry.

    Get Up-to 50% Discount for this report @ https://www.reportsweb.com/inquiry&RW00012150924/discount

    Table of Content

    1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
    1.5 Market by Application
    1.6 Study Objectives
    1.7 Years Considered

    2 Global Growth Trends
    2.1 Patient Monitoring Accessories Market Size
    2.2 Patient Monitoring Accessories Growth Trends by Regions
    2.3 Industry Trends

    3 Market Share by Key Players
    3.1 Patient Monitoring Accessories Market Size by Manufacturers
    3.2 Patient Monitoring Accessories Key Players Head office and Area Served
    3.3 Key Players Patient Monitoring Accessories Product/Solution/Service
    3.4 Date of Enter into Patient Monitoring Accessories Market
    3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product
    4.1 Global Patient Monitoring Accessories Sales by Product
    4.2 Global Patient Monitoring Accessories Revenue by Product
    4.3 Patient Monitoring Accessories Price by Product

    5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Patient Monitoring Accessories Breakdown Data by End User

    Get More Information @ https://www.reportsweb.com/inquiry&RW00012150924/buying


    Reasons to Purchase this Report:

    The report enables you to-

    -Formulate significant competitor information, analysis, and insights to improve R&D strategies

    -Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

    -Identify and understand important and diverse types of Patient Monitoring Accessories under development

    -Develop market-entry and market expansion strategies

    -Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

    -In-depth analysis of the product's current stage of development, territory and estimated launch date.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 11, 2018 ) The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Patient Examination Devices pipeline products.

    This report is prepared using data sourced from in-house databases, secondary and primary research by Publisher's team of industry experts.

    Get Access to Report Sample: @ https://www.reportsweb.com/inquiry&RW00012150934/sample

    Scope

    -Extensive coverage of the Patient Examination Devices under development

    -The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

    -The report reviews the major players involved in the development of Patient Examination Devices and list all their pipeline projects

    -The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

    -The report provides key clinical trial data of ongoing trials specific to pipeline products

    -Recent developments in the segment / industry.

    Get Up-to 50% Discount for this report @ https://www.reportsweb.com/inquiry&RW00012150934/discount

    Table of Content

    1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
    1.5 Market by Application
    1.6 Study Objectives
    1.7 Years Considered

    2 Global Growth Trends
    2.1 Patient Examination Devices Market Size
    2.2 Patient Examination Devices Growth Trends by Regions
    2.3 Industry Trends

    3 Market Share by Key Players
    3.1 Patient Examination Devices Market Size by Manufacturers
    3.2 Patient Examination Devices Key Players Head office and Area Served
    3.3 Key Players Patient Examination Devices Product/Solution/Service
    3.4 Date of Enter into Patient Examination Devices Market
    3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product
    4.1 Global Patient Examination Devices Sales by Product
    4.2 Global Patient Examination Devices Revenue by Product
    4.3 Patient Examination Devices Price by Product

    5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Patient Examination Devices Breakdown Data by End User

    Get More Information @ https://www.reportsweb.com/inquiry&RW00012150934/buying

    Reasons to Purchase this Report:
    The report enables you to-

    -Formulate significant competitor information, analysis, and insights to improve R&D strategies

    -Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

    -Identify and understand important and diverse types of Patient Examination Devices under development

    -Develop market-entry and market expansion strategies

    -Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

    -In-depth analysis of the product's current stage of development, territory and estimated launch date.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     




    (EMAILWIRE.COM, December 12, 2018 ) According to the new market research report "Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM) Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).


    Don’t miss out on business opportunities in Breast Imaging Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=897

    Based on type, the global breast imaging market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. The ionizing breast imaging technologies segment is subsegmented into analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography. The non-ionizing breast imaging technologies segment includes breast MRI, breast ultrasound, optical imaging, automated whole-breast ultrasound (AWBU), and breast thermography.

    Objectives of the study:

    • To define, describe, and forecast the breast imaging market on the basis of type
    • To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast revenue of the market segments with respect to four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World
    • To strategically profile the key players and comprehensively analyze their market shares and core competencies2
    • To track and analyze competitive developments such as new product launches and product enhancements; agreements, partnerships, and collaborations; mergers and acquisitions; and R&D activities in the breast imaging market

    Browse and in-depth TOC on "Breast Imaging Market"
    107 – Tables
    39 - Figures
    150 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/breast-imaging-technologies-market-897.html

    On the basis of type, the global breast imaging market is segmented into two major categories, namely, ionizing technologies and non-ionizing technologies. Ionizing technologies are further segmented into eight subsegments, namely, analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography. The 3D breast tomosynthesis segment is expected to grow at the highest CAGR in the next five years, owing to the increasing regulatory approvals for 3D breast tomosythesis systems, benefits offered by these systems over other technologies, and higher patient accessibility offered by these systems.

    The non-ionizing breast imaging technologies segment is classified into five subsegments, namely, breast MRI, breast ultrasound, automated whole breast ultrasound (AWBU), breast thermography, and optical imaging. The automated whole-breast ultrasound (AWBU) segment is expected to grow at the highest CAGR in the next five years, owing to benefits such as high reproducibility, high resolution power with 3D capability, lower false positives, and faster imaging.

    Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=897

    This report studies the breast imaging market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.14 Billion by 2021, at a CAGR of 8.5% from 2016 to 2021. A number of factors such as rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues are driving the growth of the global breast imaging market. However, high installation cost of breast imaging systems, side effects of radiation exposure, and errors in breast cancer screening and diagnosis are some of the major factors restraining the growth of this market. In addition, stringent regulatory approval procedures and unfavorable reimbursement scenario in developing countries are expected to further restrain the growth of this market in the coming years.

    Avail Discount on Report - https://www.marketsandmarkets.com/discountreports.asp?id=897

    The breast imaging market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to dominate the global breast imaging market, majorly due to the rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players, implementation of new breast density notification law in the U.S., rapid growth in geriatric population, and growing demand for the use of low levels or negligible radiation doses in the region. On the other hand, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. The high growth in this market can majorly be attributed to the rising patient population, increasing healthcare expenditure, higher government spending on breast cancer research studies, and implementation of several programs focused on creating awareness about the early detection of breast cancer.

    Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) According to the new market research report "Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    Don’t miss out on business opportunities in Blood Collection Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=39733117

    Blood collection is the process of acquiring blood samples from the donor for performing laboratory diagnostic tests and treating patients. This is an integral part of the blood management procedure in hospitals and blood banks centers. The global blood collection market is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5% during forecast period. The increasing prevalence of various diseases, rising number of surgeries, and growing number of accidental and trauma cases are fueling the demand for blood collection products.

    Objectives of the Study

    • To define, describe, and forecast the global blood collection market by product, method, end user, and region
    • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
    • To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
    • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
    • To profile the key players and comprehensively analyze their market shares and core competencies
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements & collaborations, and approvals in the global blood collection market

    Browse and in-depth TOC on "Blood Collection Market "
    105 – Tables
    29 - Figures
    133 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/blood-collection-market-39733117.html

    The growing number of accidental and trauma cases, rising number of surgeries, emergence of liquid biopsy, rise in the demand for blood components, and increasing prevalence of various diseases are the factors driving market growth.

    The blood collection market is segmented into product, method, end user, and region. Based on product, the market is further divided by blood collection tubes, needles and syringes, blood bags, blood collection devices, and lancets. The blood collection tubes segment is expected to dominate the market in 2017. Blood collection tubes enable the easy collection and multiple sample collection from a single venipuncture; this is driving its adoption in a wide range of applications.

    Request for Free Sample Report @
    https://www.marketsandmarkets.com/requestsample.asp?id=39733117

    Based on method, the blood collection market is segmented into manual blood collection and automated blood collection. The manual blood collection segment is expected to account for the largest share of the market in 2017. Lower costs (as compared to automated blood collection), high demand for whole blood transfusions, and the availability of a wide range of products for this method are the major factors driving market growth in this segment.

    Based on end user, the market is further segmented into hospitals and pathology laboratories, blood banks, and other end users. In 2017, hospitals and pathology laboratories segment is expected to hold the largest share of the global blood collection market. The increasing prevalence of diseases that require blood diagnosis is a key market driver for this end-user segment.

    Avail Discount on Report - https://www.marketsandmarkets.com/discountreports.asp?id=39733117

    Geographically, the global blood collection market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). North America is expected to account for the largest share of the global market in 2017. The large share of the North American region is mainly attributed to factors such as government initiatives for blood safety, increasing prevalence of lifestyle diseases, the presence of key players, and increasing adoption of automated blood collection devices in this region. The APAC region is expected to grow at the highest CAGR over the next five years. A large population base, improving healthcare infrastructure, growing medical tourism, increasing number of hospitals, and rising disposable incomes in the region are expected to offer significant growth opportunities for key players operating in the market.

    Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) According to the new market research report "Human Identification Market by Product & Services (Consumables, Instruments, Software), Technology (PCR, Capillary Electrophoresis, NGS, Microarray), Application (Forensic, Paternity Testing), End User (Forensic Laboratories) - Global Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    Don’t miss out on business opportunities in Human Identification Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=100607777

    The human identification market is expected to reach USD 1,740.2 Million by 2022 from USD 928.0 Million in 2017, at a CAGR of 13.4%. The government initiatives in forensic programs, focus of market players on expanding their reach and technological advancements are the major factors driving the growth of this market.

    Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology with DNA analysis/profiling being a key tool in this sector. The global human identification market is expected to reach USD 1740.2 Million by 2022 from USD 928.0 Million in 2017, at a CAGR of 13.4%. Technological advancement, government initiatives for forensic programs, and focus of market players on expanding their reach are the major driving factors for this market.

    The human identification market is segmented based on product & service, technology, application, and end user. Based on product & service, the market is segmented into consumables, services, instruments, and software. The consumables segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to regular and bulk purchases of consumables coupled with product launches.

    Browse and in-depth TOC on " Human Identification Market"
    100 – Tables
    32 - Figures
    160 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/human-identification-market-100607777.html

    Based on technology, the global market is segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), capillary electrophoresis, nucleic acid isolation and purification, automated liquid handling, microarrays, and rapid DNA analysis.

    In 2017, the capillary electrophoresis segment accounted for the largest share of the market. Its high efficiency, faster analysis, and requirement of a small volume of solvents are driving the uptake of this technology in human identification.

    On the basis of application, the human identification market is segmented into forensic applications, paternity identification, and other applications.

    In 2017, the forensic application segment is expected to account for the largest share of the global market. The increasing crime rate across the globe is one of the major factors driving the growth of this segment.

    By end user, the human identification market is segmented into forensic laboratories, research centers, and academic & government institutes. In 2017, the forensic laboratories segment is expected to account for the largest share of the market. The market is mainly driven by the availability of government funding and increasing number of laboratories.

    Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=100607777

    By region, the human identification market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, however, the Asian region is expected to witness the highest growth during the forecast period. Asia is expected to witness the highest CAGR, with the growth in this market centred at Japan, China, and India. The increasing number of conferences and workshops is one of the key factors driving the market in Asia.

    Avail Discount on Report -https://www.marketsandmarkets.com/discountreports.asp?id=100607777

    Key Players:
    Thermo Fisher Scientific Inc. (US), Promega Corporation (US), QIAGEN N.V. (Netherlands), Illumina Inc. (US), and Agilent Technologies Inc. (US) are the top players in this market. These companies have a broad product portfolio with comprehensive features and a strong geographical presence.

    Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 12, 2018 ) An exclusive Healthcare Payer BPO Market research report has been fabricated through the in depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation of the market by type, application, and region was done based on the thorough market analysis and validation through extensive primary inputs from industry experts, key opinion leaders of companies, and stakeholders) and secondary research (global/regional associations, trade journals, technical white papers, company’s website, annual report SEC filing, and paid databases). Further, the market has been estimated by utilizing various research methodologies and internal statistical model.

    Get Sample Copy of this Report at https://www.theinsightpartners.com/sample/TIPHC00002238/

    Healthcare Payer BPO Market report also provide a thorough understanding of the cutting-edge competitive analysis of the emerging market trends along with the drivers, restraints, challenges, and opportunities in the Healthcare Payer BPO Market to offer worthwhile insights and current scenario for making right decision. Moreover, the report also offers a 360º outlook of the market through the competitive landscape of the global industry player and helps the companies to garner Healthcare Payer BPO Market revenue by understanding the strategic growth approaches.

    The market of healthcare payer BPO market is anticipated to grow with a significant rate in the coming years, owing to factors such as, market growth with increasing total geriatric population, governing changes, and pressure to reduce rising healthcare expenses. Various technological developments in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for the players operating in the healthcare payer BPO market.

    Leading Healthcare Payer BPO Market Players:

    1 COGNIZANT

    2 Accenture

    3 Genpact

    4 HCL Technologies Limited.

    5 Wipro Limited

    6 Capgemini

    7 Xerox Corporation.

    8 HGS Ltd

    9 EXL

    10 Hewlett Packard Enterprise Development LP

    Healthcare Payer BPO Market – Global Analysis to 2025 is an exclusive and in-depth study which provides a comprehensive view of the market includes the current trend and future amplitude of the market with respect to the products/services. The report provides an overview of the Healthcare Payer BPO Market with the detailed segmentation by type, application, and region through in-depth traction analysis of the overall Healthcare Payer BPO industry. This report provides qualified research on the market to evaluate the key vendors by calibrating all the relevant products/services to understand the positioning of the major players in Healthcare Payer BPO Market.

    The report is a combination of qualitative and quantitative analysis of the Healthcare Payer BPO industry. It provides market estimation and forecasting of the Healthcare Payer BPO market for the period of 2017 to 2025, considering 2017 as the base year and 2018-2025 as the forecast period. The global market majorly considers five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SACM). The report also focuses on the exhaustive PEST analysis and extensive market dynamics during the forecast period.

    North America is expected to contribute to the largest share in the healthcare payer BPO market in the coming years, owing to factors such as, improved healthcare infrastructure and growing market with prevailing changes, increasing saturation of health insurance in United States and Canada. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to high fiscal growth, an increase in public and private healthcare expenses in Asian countries such as, India, China and Japan.

    The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    Free 20% Customization on Purchase @ https://www.theinsightpartners.com/buy/TIPHC00002238/

    Reason to Buy

    – Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Healthcare Payer BPO Market.

    – Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.

    – The key findings and recommendations highlight crucial progressive industry trends in the Healthcare Payer BPO Market, thereby allowing players to develop effective long term strategies in order to garner their market revenue.

    – Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

    – Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those restraining the growth at a certain extent.

    – Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

    The Insight partners,

    Phone: +1-646-491-9876
    Email: sales@theinsightpartners.com

    Website: http://www.theinsightpartners.com/


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 12, 2018 ) Extremities, or external articulated organs, execute several locomotive functions in a human body. A human body comprises four extremities, which include two lower limbs and two upper limbs. Extremities reconstruction refers to restoration of limbs & its functions in patients, who have suffered from limb removal owing to trauma or cancer. Extremities reconstruction is further divided into lower extremity and upper extremity.

    Get a free sample copy of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=252

    The field of extremity surgery and implants has been witnessing a number of technological innovations, such as reverse shoulder implant, stemless shoulder implant, mobile bearing ankles, and advent of new & safer implant materials. Advancements in replacement of ankle joint have provided surgeons with more options in treatment of ankle arthritis.

    FactMR’s recent study anticipates the Global Extremities Reconstruction Market to register a significant growth over the forecast period 2017 to 2022. Revenues from the global market for extremities reconstruction are expected to exceed US$ 2,000 Mn by 2022-end.

    Development of new devices by leading companies, such as Zimmer Biomet’s “Comprehensive Segmental Revision System”, have been providing solutions for implant failures. In addition, small startup organizations are focusing on development of minimally invasive endoscopic procedures for extremities reconstruction, reducing the pain and recovery time of patients. For example – “HammerFIT Extremity Reamer System” has been launched by Instratek for hammertoe surgery. These advancements and innovations are expected to spur the market growth in the near future.

    With advancements and improvements in healthcare facilities, the life expectancy of people across the globe has gained an uptick. However, the prevalence of joint disorders, such as the irreversible condition of osteoarthritis, increases indefinitely with the rise in aging population. In addition, number of cases related to sports injuries and trauma are also increasing. These factors will further drive demand for devices of extremities reconstruction across the globe. Moreover, advancements in healthcare infrastructure are also expected to fuel growth of the market. In contrast, unfavorable reimbursement policies, coupled with complication pertaining to extremities reconstruction surgeries are expected to hinder growth of the market.

    Browse here complete details about Report: https://www.factmr.com/report/252/extremities-reconstruction-market

    North America to be Fastest Expanding Market for Extremities Reconstruction

    North America is projected to be the fastest expanding market for extremities reconstruction, with sales poised to exceed US$ 600 Mn in revenues by 2022-end. The market in Asia-Pacific excluding Japan (APEJ) is expected to create an absolute $ opportunity of nearly US$ 110 Mn between 2017 and 2022.

    Among types of extremities reconstruction, elbow reconstruction will remain more lucrative than hand & wrist reconstruction, but less lucrative than shoulder reconstruction during 2017 to 2022. Ankle reconstruction will account for the lowest revenues in the market.

    Based on end-users, orthopedic clinics are expected to exhibit a relatively higher CAGR in the global Extremities Reconstruction Market through 2022. Revenues from extremities reconstruction surgeries in orthopedic clinics are expected to reach approximately US$ 600 Mn by 2022-end.

    Various biomaterials have been adopted for extremities reconstruction, including ceramic, metallic and polymeric biomaterials. Polymeric biomaterial is estimated to remain the least attractive in the market, whereas demand for ceramic biomaterial is projected to rise significantly over the forecast period.

    Competition Tracking

    FactMR’s report has listed key players in the global extremities reconstruction market, which include Acumed, LLC, Arthrex, Inc., CONMED Corporation, Depuy Synthes, Inc., Integra LifeSciences Holdings Corporation, Medtronic Plc, Smith & Nephew Plc, Zimmer Biomet Holdings, Inc., Orthofix International N.V., Wright Medical Group N.V., and Stryker Corporation.

    For any query get connect with an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=252

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 12, 2018 ) In order to study the many forthcoming movements and patterns prevailing in the global market, FactMR has included the latest Forecast report on Vaccine Delivery Devices Market to its vast database. The delivered study offers significant figures about the leading regions and applications which are functioning in the Vaccine Delivery Devices Market Forthcoming Trends by 2022, along with their market production, consumption, revenue, upcoming industry trends and forecasted market share details. Further, the accomplished market research report also anticipates that the concerned market would grow at a constructive CAGR until 2022.

    To Get Sample Copy of Current Report, Visit here - https://www.factmr.com/connectus/sample?flag=S&rep_id=178

    The global vaccine delivery devices market is expected to witness an impressive growth attributed to increasing prevalence of medical infections and diseases. Consumption of vaccine delivery devices is significant in the healthcare industry due to increasing number of diabetic patients globally. Syringes is expected to witness considerable demand among healthcare manufacturers as compared to other vaccine delivery devices in the global market. Intramuscular route is expected to witness more preference as compared to other routes of administration in the global market by the end of 2022. North America is expected to represent the largest market for vaccine delivery devices in the global market throughout 2022.

    Vaccine delivery devices is used for treatment of various medical diseases and infections. These are specialized devices that deliver a dose of drug or vaccine through a particular route of administration. Vaccines delivery devices are also increasingly used among diabetic patients to inject doses of insulin such as Novorapid and Lantus.

    A recently published report by FactMR reveals that the global vaccine delivery devices market is expected to register a healthy CAGR, and will represent a value of over US$ 4,000 Mn by the end of 2022.

    Consumption in Healthcare Industry

    Apart from injecting anesthesia before beginning with an operation, the vaccine delivery devices extend their application for various treatments in the healthcare industry. Healthcare professionals increasingly use vaccine delivery devices to inject medications in order to prevent prevalence of infections and diseases. According to the centers for disease control and prevention (CDC), vaccination should be given during the period of birth and adulthood in order to maintain lifetime protection from several infections and diseases including influenza, meningitis, and hepatitis A and B.

    Read Complete Factors about Global Market Report from Here - https://www.factmr.com/report/178/vaccine-delivery-devices-market

    As diabetes type 1 and 2 have been increasingly prevalent among the geriatric population, vaccine delivery devices has been witnessing an upsurge in demand in the healthcare industry. Healthcare professionals recommend patients who have brittle diabetes to inject certain doses of insulin such as Novorapid and Lantus regularly. Such factors have fuelled demand for vaccine delivery devices among the healthcare manufacturers.

    Manufacturers are integrating developing technologies available in the market in order to offer vaccine delivery devices that are comparatively less painful. A recent news update reveals that a new device has been developed ‘Microneedle Patches’, which is a needle-free injector and can inject a vaccine doze in a fraction of second. Bound to such factors, the global vaccine delivery devices market is expected witness a boost in growth during the predicted period.

    Intramuscular Vaccine to Register Significant Growth

    Syringes is expected to witness the highest revenue growth in the global vaccine delivery devices market. This segment is expected to represent a value of over US$ 900 Mn in the global market by the end of 2017. North America is expected to remain the largest market for vaccine delivery devices globally. Jet devices is expected to witness the second highest revenue growth in 2017. Throughout 2022, syringes is expected to register the highest CAGR growth as compared to other products in the global market, followed by jet devices.

    Intramuscular vaccine route of administration is expected to register the highest CAGR growth in the global vaccine delivery devices market, followed by subcutaneous route of administration. The intramuscular vaccine route of administration is expected to witness the highest revenue growth in the global market. This segment is expected to represent a value of over US$ 1,000 Mn by the end of 2022. Subcutaneous route of administration is expected to represent the second highest revenue growth in the global vaccine delivery devices market during the predicted period.

    Buy online this Report from Here - https://www.factmr.com/checkout/178/S

    About FactMr

    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 12, 2018 ) Bio banking equipment are equipment used in the biorepository, which stores biological samples for research purposes. Using biobanking equipment, researchers conduct tests, or perform analysis on specimens stored in a biobank. Along with equipment, consumables, software and services play an important role in helping researchers to study various types of diseases.

    Get a free sample copy of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=250

    A major factor driving the Biobanking Equipment Market Growth is growing demand for personalized medicine, which can be attributed to high unmet medical requirements for developing effective therapies. Personalized medicine implies treatments based on preferences, needs, and characteristics of patients. Individuals across the globe have been witnessed to bank their tissues and stem cells, in case any future treatment is required. Development of personalized medicine critically needs individual samples with annotated pathological and clinical data. Several research organizations are focusing on exploring ways for developments in personalized treatments with the help of biological samples. For example, in the previous year, Illumina signed 4 deals, related to biobanking, with the Vanderbilt University, Partners HealthCare, the Montreal Heart Institute, and the University of Colorado, with an aim of developing personalized medicines, and improving the overall healthcare system. This will positively impact growth of the global biobanking equipment market. Other factors influencing the market growth include growing need for discovery and development of cost-effective drugs, rise in private as well as government funding for supporting research on regenerative medicine, surging genomics research activities to study diseases, and advancements in biobanking.

    A prevalent trend being witnessed in the global biobanking equipment market is conservation of newborns’ cord blood stem cells. The market for biobanking is highly fragmented, owing to presence of various small and large vendors. Owing to similarity between products available in the market, vendors are focusing on differentiating their services based on value-added services, and automation of existing technology, for thriving in this highly competitive market. According to FactMR’s recent research, the global market for biobanking equipment is expected to exhibit a high-single digit CAGR throughout the forecast period 2017 to 2022. Sales of biobanking equipment worldwide are estimated to surpass US$ 2,000 Mn in revenues by 2022-end.

    Regenerative Medicine -  Largest Application of Biobanking Equipment

    Although regenerative medicine is projected to remain the largest application of biobanking equipment, sales for application in clinical research will exhibit the highest CAGR through 2022. Sales of biobanking equipment for application in life science research will remain relatively lower over the forecast period.

    Manual storage are poised to remain sought-after in the global biobanking equipment market. However, automated storage is expected to register the fastest expansion in the market through 2022.

    North America will remain the most attractive market for biobanking equipment, expanding at 7.6% CAGR through 2022. In addition, the markets in Japan and Latin America are estimated to witness a parallel expansion, exhibiting similar CAGRs through 2022.

    Browse here complete details about Report: https://www.factmr.com/report/250/biobanking-equipment-market

    Blood will Remain Most Lucrative Sample in the Market

    Blood is expected to be the most lucrative sample in the market, with sales expanding at the highest CAGR and accounting for the largest revenues through 2022. In contrast, sales of tissues are anticipated to exhibit the lowest CAGR through 2022, based on sample type.

    On the basis of product, equipment will remain dominant in the market, with sales poised to exceed US$ 1,300 Mn in revenues by 2022-end. Between consumables, and software & services, the latter is projected to register a comparatively faster expansion through 2022.

    Competition Tracking

    The report has profiled key players operating in the global biobanking equipment market, which include Becton, Dickinson and Company, Brooks Automation, Inc., Chart Industries, Inc., Greiner Holding AG, Hamilton Company, Merck KGaA, Panasonic Healthcare Holdings, Promega Corporation, Tecan Trading AG, Qiagen N.V., Thermo Fisher Scientific Inc., and VWR Corporation.

    For any query get connect with an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=250

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 12, 2018 ) 3D-printing is a form of additive manufacturing. Medical devices built by utilising 3d-printing technology enable perfect match to patients’ anatomy. 3D-printing medical devices have extremely complex internal structures. Flexibility of 3D printing enable medical device designers in easily making changes, eliminating the requirement of tools, or, setting up additional equipment. Some examples of 3D-printing medical devices are cranial and orthopedic implants, dental restorations, external prosthetics, and surgical instruments.

    Get a free sample copy of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=248

    3D-printing medical devices are enabling surgeons in planning surgeries, which in turn lower the operative risks faced during complex procedures, decrease duration of anesthesia exposure, and risk of infection. This further enables patients in recovering faster, and reducing the duration of hospital stay. These factors might impact growth of the global 3D-Printing Medical Devices Market. 3D printing technology is facilitating surgeons in improving the rate of success in complicated procedures. In addition, this technology is revolutionizing preclinical drug testing by making testing convenient on 3D-printed organs, an alternative to testing of animals.

    3D printing has the potential to make transformations in utilization of medical devices for treatment of patients. 3D printing technology is impacting the healthcare sector by helping in building non-implantable as well as implantable medical devices, coupled with cost-effective customizable devices. The medical 3D printing industry is being highly influenced by surging demand for patient-specific devices in maxillofacial surgery and orthopedics.

    The advent of 3D-printed tablets has created new avenues for 3D printing technology, enhancing its application in the pharmaceutical industry. A number of collaborations are being witnessed between leading market players and academic institutions across the globe, investing extensively in research and development activities, which in turn is further influencing the market growth. However, factors such as lack of structured regulatory framework, high prices of printers, unfavorable reimbursement policies, limited technical expertise, biocompatibility issues pertaining to 3D-printed medical devices, and concerns related to copyright and patent infringement are expected to hinder the market growth in the near future.

    A new report by FactMR projects the global 3D-Printing Medical Devices Market to register a staggering expansion throughout the forecast period 2017 to 2022. Global sales of 3D-printing medical devices are poised to account for revenues over US$ 1,700 Mn by 2022-end.

    Although North America is expected to dominate the global 3D-printing medical devices market, sales of these devices in Asia-Pacific excluding Japan (APEJ) will exhibit the highest CAGR through 2022. Europe will continue to be the second largest market for 3D-printing medical devices, in terms of revenues.

    Browse here complete details about Report: https://www.factmr.com/report/248/3d-printing-medical-devices-market

    Software & Services to be Sought-After among Products

    Software & services are expected to be sought-after among products in the market, accounting for over one-third revenue share of the market during 2017 to 2022. However, sales of materials will register the fastest expansion through 2022. Hospitals are expected to be the most attractive end-users of 3D-printing medical devices, with sales expected to surpass US$ 1,000 Mn in revenues by 2022-end. Revenues from sales of 3D-printing medical devices in hospitals will account for more than half share of the market during the forecast period.

    In terms of revenues, implants are anticipated to remain the largest application of 3D-printing medical devices, followed by tissue engineering. 3D-printing medical devices sales for application in external wearable devices will exhibit a relatively lower CAGR through 2022. Photo polymerization will remain the most lucrative technology for 3D-printing medical devices, followed by laser beam melting. In addition, three-dimensional printing technology, and electron beam melting technology are expected to register a parallel expansion through 2022.

    Competition Tracking

    Key market players profiled in the report include 3D Systems Corporation, Biomedical Modeling Inc., Carbon, Inc., General Electric Company, EnvisionTEC GmbH, Materialise NV, Organovo Holdings, Inc., Groupe Gorgé SA, Renishaw plc, SLM Solutions Group AG, Stratasys Ltd., and Cyfuse Biomedical K.K.

    For any query get connect with an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=248

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 12, 2018 ) Medical flexible packaging products are produced from yielding, or easily flexible materials, which readily form the shape of the items to be packed. Medical flexible packaging includes seals, high-barrier films, wraps, pouches & bags, and lids & labels. A variety of materials are used for production of medical flexible packaging, such as polypropylene, polyvinyl chloride, polyethylene terephthalate, aluminum, paper, and polyethylene.

    Get a free sample copy of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=247

    The global Medical Flexible Packaging Market will register a moderate CAGR over the forecast period 2017 to 2022, according to a new research report published by FactMR. Revenues from the global medical flexible packaging market will exceed US$ 25,000 Mn by 2022-end.

    Medical flexible packaging offers various benefits including product protection, easy shipping, and low waste, coupled with the ability of reducing weight of packaging by nearly 70%. Providing consumers with price and product differentiation, medical flexible packaging aids the preservation of hygiene and health of medical devices. Developing economies are paving huge opportunities for medical device and pharmaceutical industries, which in turn is driving demand for flexible packaging from these industries. Leading market players are currently thriving in the stagnant mature markets, with increased regulatory hurdles, and patent expirations. Brand positioning and regional expansions are key strategies being adopted by the market players. Manufacturers of flexible packaging are focusing on expansion across emerging countries for benefitting themselves from low-labor costs, and enhancing their product offerings. In addition, manufacturers are also concentrating on the combination and diversification of data analytics with manufactured products, for developing new technologically-driven products. These factors might influence growth of the market in the upcoming years.

    Other factors impacting the market growth include prevention of product damages, effective supply chain management, increased efficiency in transportation of goods, attractiveness in packaging, and being a useful tool for branding and identification. However, stringent government regulations associated with polymers, and recycling of packaging materials might impede expansion of the market. In addition, the market price trend is likely to be influenced by increasing polymer and aluminum costs, owing to political unrest.

    Browse here complete details about Report: https://www.factmr.com/report/247/medical-flexible-packaging-market

    North America is projected to remain the largest market for medical flexible packaging, with sales poised to surpass US$ 7,000 Mn in revenues by 2022-end. In addition, Europe and North America will exhibit a parallel expansion at equal CAGRs through 2022.

    Wraps are expected to be the fastest-selling product in the global medical flexible packaging market. Seals will continue to be the most lucrative product in the market, followed by high-barrier films. On the basis of application, contract packaging and implant manufacturing are expected to witness a relatively faster expansion through 2022. Pharmaceutical manufacturing will remain the largest application of medical flexible packaging during the forecast period.

    Polyvinyl chloride is anticipated to remain the most lucrative material used for medical flexible packaging, in terms of revenues. Sales of paper for production of medical flexible packaging will register the highest CAGR through 2022.

    Competition Tracking

    The report identified key players operating in the market, which include Amcor Limited, Bemis Company, Inc., Sealed Air Corporation, Huhtamaki Oyj, Mondi Group Plc, Constantia Flexibles Group GmbH, Becton Dickinson & Company, Catalent, Inc., Coveris Holdings S.A., Sonoco Products Company, Berry Group, Inc., Reynolds Group Holdings, Aptar Group, Inc., and Datwyler Holdings.

    For any query get connect with an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=247

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) According to the new market research report "Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    Don’t miss out on business opportunities in Pulmonary/ Respiratory Drug Delivery Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=179682410

    Based on canister type, the market is segmented into plain and coated canister. The coated canister segment is expected to be the fastest growing market in canister type segments in the market during the forecast period. This is attributed to advantages such as robust profile for filling, avoiding crimping, and withstanding the pressure associated with the type of propellant (HFAs or CFCs).

    Currently, North America dominates the pulmonary drug delivery market, and Asia represents the second-largest regional market. North America is further classified as U.S. and Canada.

    The U.S. is expected to account for the largest share of the North American pulmonary drug delivery market in 2016. The large share of this market can be attributed to factors such as growing prevalence of lung and respiratory diseases, technological developments, and the presence of various players focusing on the development of digital inhalers in the country.

    Browse and in-depth TOC on "Pulmonary/ Respiratory Drug Delivery Market"
    104 – Tables
    33 - Figures
    150 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug-delivery-market-179682410.html

    Presently, North America dominates the respiratory drug delivery market, and Europe represents the second-largest regional market. This is attributed to increasing technological developments in the form of digital inhalers developed by various companies and supportive reimbursement policies in the form of Medicare and Medicaid.

    Get Discount on Report @ https://www.marketsandmarkets.com/discountreports.asp?id=179682410

    Currently, North America dominates the pulmonary drug delivery devices market, and Asia represents the second-largest regional market. Moreover, the Asian market is expected to register the highest CAGR during the forecast period due to the rapidly growing geriatric population, growing adoption of an unhealthy lifestyle, growing urbanization, exposure to smoke & chemicals, and the subsequent increase in the prevalence of COPD in the region.

    Key Players:
    Prominent players in the pulmonary drug delivery market include GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.).

    Adjacent Markets Report Available - Request for bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=179682410



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) According to the new market research report "High Throughput Process Development Market by Product (Consumables (Minicolumn, Mini Bioreactor), Instruments), Services, Software, Molecule Type (mAB), Technology (Affinity Chromatography), End User (Biopharmaceutical) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    Don’t miss out on business opportunities in High Throughput Process Development Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=10249359

    Growth in the high throughput process development market is mainly driven by increasing R&D spending, technological advancements in process development, growth in the biopharmaceutical industry, and the increasing pressure to lower manufacturing costs.

    By molecule type, the high throughput process development market is classified into monoclonal antibodies and others (recombinant pro-insulin, polysaccharide vaccines, recombinant Green Fluorescent Protein (rGFP), fusion proteins, and interferon á-2a). The monoclonal antibodies segment accounted for the largest share of the global market in 2016. The large share of this segment is attributed to the increasing adoption of targeted immunotherapy and the increasing number of FDA-cleared therapeutic monoclonal antibodies.

    Browse and in-depth TOC on " High Throughput Process Development Market"
    102 – Tables
    35 - Figures
    152 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/high-throughput-process-development-market-10249359.html

    Based on end user, the market is categorized into biopharmaceutical companies, contract research organizations and academic research institutes. Biopharmaceutical companies accounted for the largest share of the global high throughput process development market in 2016. The contract manufacturing organizations segment, on the other hand, is expected to be the fastest-growing end-user segment of the market during the forecast period. High R&D investments by pharmaceutical and biopharmaceutical companies to accelerate drug manufacturing and increasing pressure from regulatory authorities to lower the cost of production are the major factors driving the growth of the biopharmaceutical manufacturers end-user segment.

    Based on technology, the market is categorized into chromatography, ultraviolet-visible spectroscopy, and others (ELISA, chip electrophoresis, SPR, and qPCR). The chromatography segment accounted for the largest share of the global high throughput process development market in 2016.

    The chromatography segment is further divided into ion exchange chromatography (IEC), affinity chromatography (AC), multimodal chromatography (MC), and others (hydrophobic charge induction chromatography (HCIC) and size exclusion chromatography). The affinity chromatography segment accounted for the largest share of the chromatography high throughput process development in 2016. Owing to the advantages of affinity chromatography over other chromatography such as high selectivity, high flow rate and its capacity for extensive removal of process-related impurities such as host cell proteins, DNA, and cell culture media component are driving the growth of the market.

    Discount Available on Report @ https://www.marketsandmarkets.com/discountreports.asp?id=10249359

    Factors such as the high cost of technology and equipment in this market and the la ck of adequate infrastructural facilities are restraining the growth of this market to a certain extent.

    Geographically, North America (comprising the US and Canada) accounted for the largest share of the global high throughput process development market in 2016. Factors such as increasing R&D spending by pharmaceutical and biopharmaceutical companies, growing demand for technical tools for improving the production quality of biological materials, collective pressure towards lowering the cost of manufacturing biological materials, rising demand for reducing product development timelines, and the presence of major players in this region are driving the growth of the North American market.

    Key Players
    Major players operating in the high throughput process development market include Danaher (US), GE Healthcare (US), Agilent Technologies (US), Merck Millipore (Germany), and Thermo Fisher Scientific (US).

    Adjacent Markets Report Available - Request for bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=10249359



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 12, 2018 ) According to the new market research "Cardiac Surgery Instruments Market by Product (Clamps, Forceps, Scalpel, Scissors, Needle Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery, Pediatric Surgery, Heart Transplant), & End User (Hospital, ASC) - Global Forecast to 2022" published by MarketsandMarkets, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and Rest of the World (RoW)

    Don’t miss out on business opportunities in Cardiac Surgery Instruments Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow:
    https://www.marketsandmarkets.com/speaktoanalyst.asp?id=162566843

    The global cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017, at a CAGR of 7.1%. The growth of the market is mainly driven by factors such as growing prevalence of cardiac conditions and subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. However, adoption of alternative surgical methods and lack of Medicare payments are the major factors that may restrain the growth of this market to a certain extent during the forecast period.

    The report segments the market based on products, applications, end user, and region. On the basis of products, the market is segmented into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments. Forceps are expected to account for the largest share of the market, in 2017. The growth of the forceps segment is attributed to the increase in the number of cardiac surgery procedures and the repeated use of forceps in most surgeries.

    Based on application, the market is further segmented into coronary artery bypass graft (CABG), heart valve surgery, pediatric cardiac surgery, and other applications. CABG segment is expected to grow at the highest CAGR during the forecast period. CABG forms the largest and fastest-growing application segment of the market. This is mainly attributed to the high incidence of cardiac diseases and resulting increase in the number of surgical procedures.

    Browse and in-depth TOC on “Cardiac Surgery Instruments Market"
    82 – Tables
    34 – Figures
    150 – Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/cardiac-surgery-instrument-market-162566843.html

    Based on region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of this market in 2017. However, the Asian market is expected to grow at the highest CAGR mainly due to the increasing awareness programs, high incidence of cardiac diseases, rising funding for cardiac research, and improvements in the healthcare sector of Asian countries.

    Discount Available on Report @ https://www.marketsandmarkets.com/discountreports.asp?id=162566843

    Market Players
    Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Teleflex Incorporated (U.S.), Medline Industries, Inc. (U.S.), KLS Martin Group (U.S.), Stille (Sweden), Sklar Surgical Instruments (U.S.), Symmetry Surgical Inc. (U.S.), Delacroix-Chevalier (France), Wexler Surgical (U.S.), Surgins (U.K.), Surtex Instruments Ltd. (U.K.), Cardivon Surgical Inc. (China), Rumex International Corporation (U.S.), and Scanlan International (U.S.).

    Adjacent Markets Report Available - Request for bundle reports: https://www.marketsandmarkets.com/RequestBundleReport.asp?id=162566843


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

older | 1 | .... | 1111 | 1112 | (Page 1113) | 1114 | 1115 | .... | 1146 | newer